Skip to main content

Table 1 Gamma Irradiation Therapy (IR) and Therapeutic Electromagnetic Field Therapy (TEMF) on Liver and Spleen Weight (Means ± SEM)

From: Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis

Therapy Group

n

Liver weight (grams)

Spleen weight (grams)

Early 1

   

Control

5

0.94 ± 0.04

0.107 ± 0.009

IR

5

0.87 ± 0.07

0.031 ± 0.004

TEMF

5

1.04 ± 0.05

0.110 ± 0.006

TEMF/IR

5

0.93 ± 0.04

0.033 ± 0.004

Late 2

   

Control

9

1.26 ± 0.07

0.166 ± 0.008

IR

20

1.17 ± 0.03

0.146 ± 0.008

TEMF

10

1.16 ± 0.05

0.145 ± 0.012

TEMF/IR

10

1.15 ± 0.05

0.151 ± 0.014

  1. 1Mice sacrificed one day after last irradiation treatment.
  2. 2Mice sacrificed 22 days after last irradiation treatment.
  3. Results of Statistical Analyses:
  4. 1. Liver weight: No significant differences among treatment groups.
  5. 2. Spleen weight: At early kill, groups treated with gamma irradiation show significant (p < 0.01) loss of weight compared to groups not treated with gamma irradiation. In late kill, no significant differences were detected.
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us